← All stocks

MoonLake Immunotherapeutics

MLTX Net selling
CIK 0001821586 #2320 in the set updated 17 Sep 2026
Bought (12 mo)
$98.81K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$129.89M
$11.32M on a plan · $0.00 straight out of an exercise
Sold at will
$118.57M
14 of 32 sales
Net
−$129.80M
−$118.47M against sales at will

By person

7 insiders · 33 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
BVF PARTNERS L P/IL entity
Director
$62.96M (3)
−$62.96M
1,039,238
$20.78M
−84.7%
Chen Bihua
Former 10% Owner
$46.87M (5)
−$46.87M
1,994,173
$39.88M
−76.5%
Santos da Silva Jorge
Chief Executive Officer
$8.73M (7)
−$8.73M
2,774,893
$55.50M
−12.7%
Reich Kristian
Chief Scientific Officer
$8.14M (10) scheduled
−$8.14M
2,746,587
$54.93M
−14.5%
Bodenstedt Matthias
Chief Financial Officer
$98.81K (1)
$3.20M (7) scheduled
−$3.10M
1,115,435
$22.31M
+36.8%
Sturge Simon
Director
171,980
$3.44M
−49.9%
Moukheibir Catherine
Director
0
$0.00

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Reich Kristian
27 Jul 2026
Chief Scientific Officer
Sold on a plan indirect
1,100
$20.00
$22.00K
Reich Kristian
22 Jul 2026
Chief Scientific Officer
Sold on a plan indirect
2,448
$20.00
$48.96K
Reich Kristian
21 Jul 2026
Chief Scientific Officer
Sold on a plan indirect
50,000
$20.02
$1.00M
Reich Kristian
20 Jul 2026
Chief Scientific Officer
Sold on a plan indirect
43,700
$20.09
$877.93K
Reich Kristian
15 Jul 2026
Chief Scientific Officer
Sold on a plan indirect
16,105
$20.01
$322.26K
Santos da Silva Jorge
10 Jul 2026
Chief Executive Officer
Sold on a plan
68,289
$20.02
$1.37M
Santos da Silva Jorge
9 Jul 2026
Chief Executive Officer
Sold on a plan
33,936
$20.01
$679.06K
Santos da Silva Jorge
1 Jul 2026
Chief Executive Officer
Sold on a plan
47,775
$20.03
$956.93K
Bodenstedt Matthias
22 Jun 2026
Chief Financial Officer
Sold on a plan
39,120
$22.04
$862.20K
Bodenstedt Matthias
18 Jun 2026
Chief Financial Officer
Sold on a plan
2,794
$19.60
$54.76K
Reich Kristian
17 Jun 2026
Chief Scientific Officer
Sold on a plan indirect
50,000
$19.43
$971.50K
Bodenstedt Matthias
17 Jun 2026
Chief Financial Officer
Sold on a plan
15,082
$19.68
$296.81K
Reich Kristian
16 Jun 2026
Chief Scientific Officer
Sold on a plan indirect
50,000
$18.70
$935.00K
Reich Kristian
15 Jun 2026
Chief Scientific Officer
Sold on a plan indirect
50,000
$18.89
$944.50K
Bodenstedt Matthias
11 May 2026
Chief Financial Officer
Sold on a plan
13,653
$20.02
$273.33K
Bodenstedt Matthias
14 Apr 2026
Chief Financial Officer
Sold on a plan
2,426
$19.56
$47.45K
Bodenstedt Matthias
10 Apr 2026
Chief Financial Officer
Sold on a plan
1,925
$19.51
$37.56K
Bodenstedt Matthias
9 Apr 2026
Chief Financial Officer
Sold on a plan
85,870
$18.94
$1.63M

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 0
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 1,406,652
History held since 22 Oct 2020